Back to Authors

He, Shun

https://orcid.org/0000-0002-8389-9001

Mayo Clinic

Harvard University

Citations 1

Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis
Anzai, Atsushi , Mindur, John E. , Halle, Lennard , Sano, Soichi , Choi, Jennifer L. , He, Shun , McAlpine, Cameron S. , Chan, Christopher T. , Kahles, Florian , Valet, Colin, Fenn, Ashley M., Rattik, Sara , Iwamoto, Yoshiko , Fairweather, DeLisa , Nahrendorf, Matthias , Świrski, Filip K. , Fairweather, DeLisa , Libby, Peter , Nahrendorf, Matthias , Swirski, Filip K , Nairz, Manfred , Walsh, Kenneth , Libby, Peter

Journal of Experimental Medicine | January 22, 2019 | Volume: 216 | Issue: 2 | Pages: 369-383

10.1084/jem.20180722 Get It

Acquisition of self-reactive effector CD4+ T cells is a major component of the autoimmune response that can occur during myocarditis, an inflammatory form of cardiomyopathy. Although the processes by which self-reactive T cells gain effector function have received considerable attention, how these T cells contribute to effector organ inflammation and damage is less clear. Here, we identified an IL-3–dependent amplification loop that exacerbates autoimmune inflammation. In experimental myocarditis, we show that effector organ–accumulating autoreactive IL-3+ CD4+ T cells stimulate IL-3R+ tissue macrophages to produce monocyte-attracting chemokines. The newly recruited monocytes differentiate into antigen-presenting cells that stimulate local IL-3+ CD4+ T cell proliferation, thereby amplifying organ inflammation. Consequently, Il3−/− mice resist developing robust autoimmune inflammation and myocardial dysfunction, whereas therapeutic IL-3 targeting ameliorates disease. This study defines a mechanism that orchestrates inflammation in myocarditis, describes a previously unknown function for IL-3, and identifies IL-3 as a potential therapeutic target in patients with myocarditis.